Study on quality use of angiotensin II receptor blockers -Comparison between valsartan and olmesartan
Phase 4
Completed
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000003776
- Lead Sponsor
- Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
I. Have an anamnesis to the drug II. Pregnant or potentially pregnant women III. Severe renal impairment (more than twice the standard value of serum creatinine, including the case in hemodialysis) IV. Have been diagnosed with secondary hypertension V. Shift workers and night workers (Have an irregular rhythm of life-style) VI.Judged inappropriate to participate in this study by a doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method # Decrease rate of nocturnal blood pressure # Change in the fall of blood pressure during night-time # Changes in urine albumin level and serum cystatin C concentration
- Secondary Outcome Measures
Name Time Method